Sulforaphane induces miR135b-5p and its target gene, RASAL2, thereby inhibiting the progression of pancreatic cancer
Pancreatic ductal adenocarcinoma (PDA) is one of the most lethal tumors, with poor therapeutic options in the advanced state. The broccoli-derived anti-inflammatory agent sulforaphane was shown to inhibit the progression of pancreatic cancer and other tumor entities. We examined the involvement of p...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
6 April 2019
|
| In: |
Molecular therapy. Oncolytics
Year: 2019, Jahrgang: 14, Pages: 74-81 |
| ISSN: | 2372-7705 |
| DOI: | 10.1016/j.omto.2019.03.011 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1016/j.omto.2019.03.011 Verlag: http://www.sciencedirect.com/science/article/pii/S2372770519300476 
|
| Verfasserangaben: | Libo Yin, Xi Xiao, Christina Georgikou, Yiqiao Luo, Li Liu, Jury Gladkich, Wolfgang Gross, and Ingrid Herr |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 168063500X | ||
| 003 | DE-627 | ||
| 005 | 20240323101640.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191029s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.omto.2019.03.011 |2 doi | |
| 035 | |a (DE-627)168063500X | ||
| 035 | |a (DE-599)KXP168063500X | ||
| 035 | |a (OCoLC)1341249475 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Yin, Libo |d 1982- |e VerfasserIn |0 (DE-588)1160784256 |0 (DE-627)1024209342 |0 (DE-576)506190773 |4 aut | |
| 245 | 1 | 0 | |a Sulforaphane induces miR135b-5p and its target gene, RASAL2, thereby inhibiting the progression of pancreatic cancer |c Libo Yin, Xi Xiao, Christina Georgikou, Yiqiao Luo, Li Liu, Jury Gladkich, Wolfgang Gross, and Ingrid Herr |
| 264 | 1 | |c 6 April 2019 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 29.10.2019 | ||
| 520 | |a Pancreatic ductal adenocarcinoma (PDA) is one of the most lethal tumors, with poor therapeutic options in the advanced state. The broccoli-derived anti-inflammatory agent sulforaphane was shown to inhibit the progression of pancreatic cancer and other tumor entities. We examined the involvement of pancreatic cancer cell lines were evaluated by microRNA and gene expression arrays, bioinformatics, in silico analysis, qRT-PCR, western blotting, immunohistochemistry, in situ hybridization, self-renewal and differentiation assays, and in vivo xenograft studies. We selected the top nine differentially expressed microRNAs, and miR135b-5p was chosen as the most important candidate for the sulforaphane-induced upregulation of the tumor suppressor gene RASAL2. The expression of miR135b-5p and RASAL2 was almost absent in malignant pancreatic tissues and cell lines, but not in their normal counterparts. Lipofection of miR135b-5p enhanced RASAL2 expression and inhibited ERK1/2 signaling, viability, self-renewal capacity, and tumor growth. These results indicate that miR135b-5p acts as a tumor suppressor via the induction of RASAL2 in PDA. | ||
| 650 | 4 | |a broccoli | |
| 650 | 4 | |a cancer | |
| 650 | 4 | |a microRNA | |
| 650 | 4 | |a pancreatic cancer | |
| 650 | 4 | |a RASAL2 | |
| 650 | 4 | |a sulforaphane | |
| 700 | 1 | |a Georgikou, Christina |d 1991- |e VerfasserIn |0 (DE-588)1194571549 |0 (DE-627)167677842X |4 aut | |
| 700 | 1 | |a Herr, Ingrid |e VerfasserIn |0 (DE-588)114884242 |0 (DE-627)691233276 |0 (DE-576)168702436 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Molecular therapy. Oncolytics |d Cambridge, MA : Cell Press, 2014 |g 14(2019), Seite 74-81 |h Online-Ressource |w (DE-627)843857420 |w (DE-600)2842549-2 |w (DE-576)453321577 |x 2372-7705 |7 nnas |a Sulforaphane induces miR135b-5p and its target gene, RASAL2, thereby inhibiting the progression of pancreatic cancer |
| 773 | 1 | 8 | |g volume:14 |g year:2019 |g pages:74-81 |g extent:8 |a Sulforaphane induces miR135b-5p and its target gene, RASAL2, thereby inhibiting the progression of pancreatic cancer |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.omto.2019.03.011 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S2372770519300476 |x Verlag |
| 951 | |a AR | ||
| 992 | |a 20191029 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 114884242 |a Herr, Ingrid |m 114884242:Herr, Ingrid |d 910000 |d 910200 |e 910000PH114884242 |e 910200PH114884242 |k 0/910000/ |k 1/910000/910200/ |p 8 |y j | ||
| 998 | |g 1194571549 |a Georgikou, Christina |m 1194571549:Georgikou, Christina |p 3 | ||
| 998 | |g 1160784256 |a Yin, Libo |m 1160784256:Yin, Libo |d 50000 |e 50000PY1160784256 |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN168063500X |e 3531028391 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 29.10.2019"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"168063500X","language":["eng"],"person":[{"family":"Yin","given":"Libo","display":"Yin, Libo","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Christina","family":"Georgikou","role":"aut","display":"Georgikou, Christina","roleDisplay":"VerfasserIn"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Herr, Ingrid","given":"Ingrid","family":"Herr"}],"title":[{"title":"Sulforaphane induces miR135b-5p and its target gene, RASAL2, thereby inhibiting the progression of pancreatic cancer","title_sort":"Sulforaphane induces miR135b-5p and its target gene, RASAL2, thereby inhibiting the progression of pancreatic cancer"}],"physDesc":[{"extent":"8 S."}],"relHost":[{"title":[{"partname":"Oncolytics","title":"Molecular therapy","title_sort":"Molecular therapy"}],"pubHistory":["Volume 1 (2014)-volume 31 (2023)"],"part":{"year":"2019","pages":"74-81","text":"14(2019), Seite 74-81","volume":"14","extent":"8"},"disp":"Sulforaphane induces miR135b-5p and its target gene, RASAL2, thereby inhibiting the progression of pancreatic cancerMolecular therapy. Oncolytics","type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 19.09.2024"],"recId":"843857420","corporate":[{"display":"American Society of Gene & Cell Therapy","roleDisplay":"Herausgebendes Organ","role":"isb"}],"language":["eng"],"origin":[{"publisher":"Cell Press ; Nature Publishing Group","dateIssuedKey":"2017","dateIssuedDisp":"2017-","publisherPlace":"Cambridge, MA ; London"}],"id":{"eki":["843857420"],"zdb":["2842549-2"],"issn":["2372-7705"]},"name":{"displayForm":["American Society of Gene & Cell Therapy"]},"physDesc":[{"extent":"Online-Ressource"}]}],"name":{"displayForm":["Libo Yin, Xi Xiao, Christina Georgikou, Yiqiao Luo, Li Liu, Jury Gladkich, Wolfgang Gross, and Ingrid Herr"]},"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"6 April 2019"}],"id":{"eki":["168063500X"],"doi":["10.1016/j.omto.2019.03.011"]}} | ||
| SRT | |a YINLIBOGEOSULFORAPHA6201 | ||